These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8111810)

  • 41. Pharmacokinetics and effects on fecal blood loss of a controlled release potassium chloride tablet.
    Tannen RL; Cordano A
    J Pharmacol Exp Ther; 1978 Jan; 204(1):240-6. PubMed ID: 304099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioequivalence of a slow-release potassium tablet and a liquid potassium supplement.
    Lowance DC; Murad F; Darrow WR; Bonus L
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):204-8. PubMed ID: 7095919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly.
    Grymonpre RE; Didur CD; Montgomery PR; Sitar DS
    Ann Pharmacother; 1998; 32(7-8):749-54. PubMed ID: 9681089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Klotrix and other slow-release potassium tablets.
    Med Lett Drugs Ther; 1981 Jan; 23(1):3-4. PubMed ID: 7453668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ulceration and stricture of the esophagus due to oral potassium chloride (slow release tablet) therapy.
    Lambert JR; Newman A
    Am J Gastroenterol; 1980 Jun; 73(6):508-11. PubMed ID: 7424872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure.
    Rao CR
    J Int Med Res; 1982; 10(5):357-60. PubMed ID: 6754508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect on plasma potassium of a combined preparation of frusemide and slow-release potassium chloride (Diumide-K Continus tablets).
    Lewis JG
    J Int Med Res; 1979; 7(5):354-9. PubMed ID: 499643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic assessment of Slow-K and K-tab potassium chloride formulations in hypertensive patients treated with thiazide diuretics.
    Skoutakis VA; Carter CA; Acchiardo SR
    Drug Intell Clin Pharm; 1987 May; 21(5):445-50. PubMed ID: 3556129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drugs taken by a population based sample of subjects 65 years and over in New Zealand.
    Campbell AJ; McCosh L; Reinken J
    N Z Med J; 1983 May; 96(732):378-80. PubMed ID: 6573604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice.
    Shulman LP; Portman DJ; Lee WC; Balu S; Joshi AV; Cobden D; Wang Q; Pashos CL
    J Womens Health (Larchmt); 2008 May; 17(4):569-78. PubMed ID: 18429700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug taking behavior of internal medicine inpatients].
    Ziessler M; Mehlhorn J; Zimmermann S
    Z Gesamte Inn Med; 1990 Mar; 45(6):158-61. PubMed ID: 2375170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hypokalemia, potassium loss and liver cirrhosis. Value of potassium chloride sustained-release tablets].
    Lévy VG; Caroli J
    Therapeutique; 1971 Dec; 47(10):845-51. PubMed ID: 5145546
    [No Abstract]   [Full Text] [Related]  

  • 53. Bioavailability and pharmacokinetics of a new sustained-release potassium chloride tablet.
    Betlach CJ; Arnold JD; Frost RW; Leese PT; Gonzalez MA
    Pharm Res; 1987 Oct; 4(5):409-11. PubMed ID: 3508550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of a thiazide diuretic combined with slow-release potassium.
    Practitioner; 1968 May; 200(199):714-9. PubMed ID: 4870205
    [No Abstract]   [Full Text] [Related]  

  • 55. Complications of "slow-K" therapy.
    Sandor F
    J R Coll Gen Pract; 1976 Aug; 26(169):595-8. PubMed ID: 966209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical studies of Slow-k].
    Murakami E
    Nihon Rinsho; 1977 Dec; 35(12):4303-5. PubMed ID: 342762
    [No Abstract]   [Full Text] [Related]  

  • 57. Side-effects of potassium chloride in products with different dissolution rates.
    Graffner C; Sjögren J
    Acta Pharm Suec; 1971 Mar; 8(1):19-26. PubMed ID: 5575870
    [No Abstract]   [Full Text] [Related]  

  • 58. A study on the effects of a combined frusemide and controlled release potassium tablet (Diumide-K Continus tablets) on gastrointestinal mucosa.
    McLoughlin JC
    Br J Clin Pract; 1984 Mar; 38(3):99-101. PubMed ID: 6712879
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical studies of a sustained-release potassium salt preparation].
    Nukada T
    Nihon Rinsho; 1977 Dec; 35(12):4305-9. PubMed ID: 342763
    [No Abstract]   [Full Text] [Related]  

  • 60. Sustained release tablets for potassium chloride administration. A pharmacological study.
    Bervenmark H; Eriksson G; Ljungberg S; Paalzow L
    Acta Pharm Suec; 1966 Feb; 3(1):45-58. PubMed ID: 5909431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.